Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (3,5-dichloro-4-hydroxyphenyl)-(1,1-dioxo-2h-1,3-benzothiazol-3-yl)methanone
2. Fyu-981
1. 1285572-51-1
2. Fyu-981
3. Dotinurad [inn]
4. (3,5-dichloro-4-hydroxyphenyl)(1,1-dioxidobenzo[d]thiazol-3(2h)-yl)methanone
5. 305eb53128
6. (3,5-dichloro-4-hydroxyphenyl)-(1,1-dioxo-2h-1,3-benzothiazol-3-yl)methanone
7. Urece
8. Methanone, (3,5-dichloro-4-hydroxyphenyl)(1,1-dioxido-3(2h)-benzothiazolyl)-
9. Urece (tn)
10. Dotinurad (jan/inn)
11. Dotinurad [jan]
12. Dotinurad [who-dd]
13. Fyu981
14. Chembl4594446
15. Schembl10322525
16. Gtpl11389
17. Unii-305eb53128
18. Ex-a5737
19. Bdbm50561689
20. Hy-109031
21. Cs-0030545
22. D11071
23. 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole
Molecular Weight | 358.2 g/mol |
---|---|
Molecular Formula | C14H9Cl2NO4S |
XLogP3 | 2.9 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 1 |
Exact Mass | 356.9629343 g/mol |
Monoisotopic Mass | 356.9629343 g/mol |
Topological Polar Surface Area | 83.1 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 538 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Uricosuric Agents
Gout suppressants that act directly on the renal tubule to increase the excretion of uric acid, thus reducing its concentrations in plasma. (See all compounds classified as Uricosuric Agents.)
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?